Quantcast
Last updated on April 18, 2014 at 16:49 EDT

Latest Dabigatran Stories

2013-11-22 23:34:57

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) November 22, 2013 The prescription drug resource center DrugRisk.com is announcing new information added to the site for patients taking the blood thinner Pradaxa. Recent court records show the number of lawsuits alleging the drug caused internal bleeding injuries has grown this month*. The DrugRisk center was...

2013-11-19 12:10:08

Abstract 17765 (Room C140) For the first time, an antidote developed specifically for dabigatran successfully reversed the effects of the anti-clotting medication in healthy volunteers, according to research presented at the American Heart Association's Scientific Sessions 2013. New oral anti-clotting medications such as dabigatran (Pradaxa) are easier to take than warfarin. However, up until now, there have been no specific antidotes available to reverse the effects of these new...

2013-11-19 08:28:10

New clinical trials of PRADAXA in different patient populations to add data to RE-VOLUTION®, BI's extensive clinical trial program RIDGEFIELD, Conn., Nov. 19, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. plans to initiate two new global clinical trials of PRADAXA. One of the new trials, RE-DUAL PCI(TM) ("Randomized Evaluation of Dual Therapy with Dabigatran vs. Triple Therapy Strategy with Warfarin in Patients with NVAF that have undergone PCI with Stenting"), is designed...

2013-11-18 12:30:28

New data include results for some PRADAXA patients studied for up to 6.7 years RIDGEFIELD, Conn., Nov. 18, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new, long-term, combined analysis of the pivotal Phase III RE-LY® trial and its extension safety study RELY-ABLE®. The data showed that after a median follow up of 4.6 years, with some patients followed up to 6.7 years, rates of stroke/systemic embolism and major bleeding were consistent with...

2013-11-18 12:29:50

Data indicate the antidote may be able to achieve immediate, complete and sustained reversal of dabigatran-induced anticoagulation in healthy humans RIDGEFIELD, Conn., Nov. 18, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results showing that its investigational fully humanized antibody fragment (Fab) rapidly reversed the anticoagulation effect of dabigatran in healthy male volunteers. These results, presented today during the American Heart Association's...

2013-11-14 23:33:25

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) November 14, 2013 The drug safety center at DrugNews.net is new information on the site for patients taking the blood thinner Pradaxa. A recent medication safety report listed the drug highest for the number of side effects reported to the FDA last year*. DrugNews gives those taking popular prescription drugs...

2013-11-13 23:27:31

As The Courts Continue To Receive Pradaxa Lawsuits, Wright & Schulte LLC Files A Pradaxa Internal Bleeding Lawsuit Aleging A Woman’s Wrongful Death Was From a Gastrointestinal Hemorrhage Due To Pradaxa Columbus, OH (PRWEB) November 13, 2013 As The Courts Continue To Receive Pradaxa Lawsuits, Wright & Schulte LLC Files A Pradaxa Internal Bleeding Lawsuit Aleging A Woman’s Wrongful Death Was From a Gastrointestinal Hemorrhage Due To Pradaxa Pradaxa internal bleeding lawsuits...

2013-11-12 08:37:08

RIDGEFIELD, Conn., Nov. 12, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced that data from eight company-sponsored PRADAXA studies will be presented at the American Heart Association's (AHA) Scientific Sessions in Dallas, November 16 to 20, 2013. The presentations - a mix of new clinical, epidemiological and pre-clinical data - will include long-term (median 4.6 years, maximum 6.7 years) follow-up data from the pivotal Phase III RE-LY® trial and its extension...

2013-11-06 23:29:40

There are now almost 1,600 cases in the Pradaxa federal multidistrict litigation over allegations of life-threatening bleeding problems. National network of attorneys continues to offer consumers free legal consultations over compensation rights. San Diego, CA (PRWEB) November 06, 2013 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople announced today another update involving allegations that popular blood thinner Pradaxa may cause internal bleeding...

2013-11-06 23:01:34

The Firm is investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered life-threatening episodes of internal bleeding while using Pradaxa. New York, NY (PRWEB) November 06, 2013 More than 1,700 Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) filed on behalf of patients who allegedly suffered life-threatening episodes of internal bleeding while using Pradaxa continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District...